Amneal Pharmaceuticals Inc (NASDAQ: AMRX) is -7.20% lower on its value in year-to-date trading and has touched a low of $6.29 and a high of $9.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMRX stock was last observed hovering at around $7.50 in the last trading session, with the day’s loss setting it -0.15%.
Currently trading at $7.35, the stock is -1.42% and -7.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.27 million and changing -2.00% at the moment leaves the stock -9.99% off its SMA200. AMRX registered 10.36% gain for a year compared to 6-month loss of -15.81%.
The stock witnessed a 1.94% gain in the last 1 month and extending the period to 3 months gives it a -6.01%, and is 1.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.53% over the week and 4.07% over the month.
Amneal Pharmaceuticals Inc (AMRX) has around 8300 employees, a market worth around $2.30B and $2.83B in sales. Fwd P/E is 9.00. Profit margin for the company is -0.46%. Distance from 52-week low is 16.85% and -22.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.62%).
The EPS is expected to grow by 21.84% this year
The shares outstanding are 313.38M, and float is at 134.73M with Short Float at 4.53%.
The top institutional shareholder in the company is UBS GROUP AG with over 21.85 million shares valued at $138.74 million. The investor’s holdings represent 7.0684 of the AMRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 13.99 million shares valued at $88.86 million to account for 4.5271 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 12.33 million shares representing 3.9884 and valued at over $78.29 million, while BLACKROCK INC. holds 3.6499 of the shares totaling 11.28 million with a market value of $71.64 million.
Amneal Pharmaceuticals Inc (AMRX) Insider Activity
The most recent transaction is an insider sale by Kiely John, the company’s Director. SEC filings show that Kiely John sold 50,000 shares of the company’s common stock on May 12 ’25 at a price of $7.59 per share for a total of $0.38 million. Following the sale, the insider now owns 0.26 million shares.
Still, SEC filings show that on May 05 ’25, Patel Gautam (Director) disposed off 4,900 shares at an average price of $8.00 for $39200.0. The insider now directly holds 1,720,218 shares of Amneal Pharmaceuticals Inc (AMRX).
